ID: ALA3780714

Max Phase: Preclinical

Molecular Formula: C32H34N6O4S

Molecular Weight: 598.73

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NS(C)(=O)=O)c3)c3ccccc23)cc1

Standard InChI:  InChI=1S/C32H34N6O4S/c1-21-10-12-23(13-11-21)38-30(19-28(36-38)32(2,3)4)35-31(39)34-26-14-15-27(25-9-7-6-8-24(25)26)42-20-22-16-17-33-29(18-22)37-43(5,40)41/h6-19H,20H2,1-5H3,(H,33,37)(H2,34,35,39)

Standard InChI Key:  OIUJKHYYCHMFEB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 598.73

Molecular Weight (Monoisotopic): 598.2362

AlogP: 6.62

#Rotatable Bonds: 8

Polar Surface Area: 127.24

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 7.63

CX Basic pKa: 1.90

CX LogP: 6.04

CX LogD: 5.87

Aromatic Rings: 5

Heavy Atoms: 43

QED Weighted: 0.18

Np Likeness Score: -1.53

References

1. Onions ST, Ito K, Charron CE, Brown RJ, Colucci M, Frickel F, Hardy G, Joly K, King-Underwood J, Kizawa Y, Knowles I, Murray PJ, Novak A, Rani A, Rapeport G, Smith A, Strong P, Taddei DM, Williams JG..  (2016)  Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma.,  59  (5): [PMID:26800309] [10.1021/acs.jmedchem.5b01029]

Source

Source(1):

• Scientific Literature